These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6389698)

  • 21. Purification and characterization of streptin, a type A1 lantibiotic produced by Streptococcus pyogenes.
    Wescombe PA; Tagg JR
    Appl Environ Microbiol; 2003 May; 69(5):2737-47. PubMed ID: 12732544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A response regulator gene controls production of the lantibiotic streptococcin A-FF22.
    Hynes WL; Ferretti JJ
    Dev Biol Stand; 1995; 85():635-7. PubMed ID: 8586243
    [No Abstract]   [Full Text] [Related]  

  • 23. Sequence analysis of pDN571, a plasmid encoding novel bacteriocin production in M-type 57 Streptococcus pyogenes.
    Heng NC; Burtenshaw GA; Jack RW; Tagg JR
    Plasmid; 2004 Nov; 52(3):225-9. PubMed ID: 15518879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Duplication of the lantibiotic structural gene in M-type 49 group A streptococcus strains producing streptococcin A-M49.
    Hynes WL; Friend VL; Ferretti JJ
    Appl Environ Microbiol; 1994 Nov; 60(11):4207-9. PubMed ID: 7993103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Viridins, bacteriocins of alpha-hemolytic streptococci: isolation, characterization, and partial purification.
    Dajani AS; Tom MC; Law DJ
    Antimicrob Agents Chemother; 1976 Jan; 9(1):81-8. PubMed ID: 1259394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacteriocin-like activity of group B and group C streptococci of human and of animal origin.
    Schofield CR; Tagg JR
    J Hyg (Lond); 1983 Feb; 90(1):7-18. PubMed ID: 6337211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Group A streptococcal bacteriocin. Production, purification, and mode of action.
    Tagg JR; Dajani AS; Wannamaker LW; Gray ED
    J Exp Med; 1973 Nov; 138(5):1168-83. PubMed ID: 4744922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacteriocin of a group B streptococcus: partial purification and characterization.
    Tagg JR; Dajani AS; Wannamaker LW
    Antimicrob Agents Chemother; 1975 Jun; 7(6):764-72. PubMed ID: 1155919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Megaplasmids encode differing combinations of lantibiotics in Streptococcus salivarius.
    Wescombe PA; Burton JP; Cadieux PA; Klesse NA; Hyink O; Heng NC; Chilcott CN; Reid G; Tagg JR
    Antonie Van Leeuwenhoek; 2006 Oct; 90(3):269-80. PubMed ID: 16871420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salivaricin G32, a Homolog of the Prototype Streptococcus pyogenes Nisin-Like Lantibiotic SA-FF22, Produced by the Commensal Species Streptococcus salivarius.
    Wescombe PA; Dyet KH; Dierksen KP; Power DA; Jack RW; Burton JP; Inglis MA; Wescombe AL; Tagg JR
    Int J Microbiol; 2012; 2012():738503. PubMed ID: 22567013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The streptococcal inhibitor of complement (SIC) protects Streptococcus pyogenes from bacteriocin-like inhibitory substance (BLIS) from Streptococcus salivarius.
    Minami M; Ohmori D; Tatsuno I; Isaka M; Kawamura Y; Ohta M; Hasegawa T
    FEMS Microbiol Lett; 2009 Sep; 298(1):67-73. PubMed ID: 19594623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Typing of Actinomyces pyogenes by its production and susceptibility to bacteriocin-like inhibitors.
    Lämmler C
    Zentralbl Bakteriol; 1990 Jun; 273(2):173-8. PubMed ID: 2400533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Incidence and distribution of Streptococcus pyogenes type M in patients treated at the Dr. Fran Mihaljević Infectious Disease Clinic in Zagreb from 1990 to 1996].
    Bejuk D; Begovac J
    Acta Med Croatica; 2002; 56(3):85-91. PubMed ID: 12630338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of arginine deiminase in thymic atrophy during experimental Streptococcus pyogenes infection.
    Starikova EA; Golovin AS; Vasilyev KA; Karaseva AB; Serebriakova MK; Sokolov AV; Kudryavtsev IV; Burova LA; Voynova IV; Suvorov AN; Vasilyev VB; Freidlin IS
    Scand J Immunol; 2019 Feb; 89(2):e12734. PubMed ID: 30471128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA fingerprinting of Streptococcus zooepidemicus (Lancefield group C) as an aid to epidemiological study.
    Skjold SA; Quie PG; Fries LA; Barnham M; Cleary PP
    J Infect Dis; 1987 Jun; 155(6):1145-50. PubMed ID: 3572034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Typing of Pseudomonas cepacia by bacteriocin susceptibility and production.
    Govan JR; Harris G
    J Clin Microbiol; 1985 Oct; 22(4):490-4. PubMed ID: 4077961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiological typing of Streptococcus pyogenes by pyrolysis mass spectrometry.
    Magee JT; Hindmarch JM; Burnett IA; Pease A
    J Med Microbiol; 1989 Dec; 30(4):273-8. PubMed ID: 2689652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bacteriophage content of M49 strains of Streptococcus pyogenes.
    Suvorov AN; Polyakova EM; McShan WM; Ferretti JJ
    FEMS Microbiol Lett; 2009 May; 294(1):9-15. PubMed ID: 19493003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production of Antilisterial Bacteriocins from Lactic Acid Bacteria in Dairy-Based Media: A Comparative Study.
    Ünlü G; Nielsen B; Ionita C
    Probiotics Antimicrob Proteins; 2015 Dec; 7(4):259-74. PubMed ID: 26341641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purification of bacteriocin LS1 produced by human oral isolate Lactobacillus salivarius BGHO1.
    Busarcevic M; Kojic M; Dalgalarrondo M; Chobert JM; Haertlé T; Topisirovic L
    Oral Microbiol Immunol; 2008 Jun; 23(3):254-8. PubMed ID: 18402613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.